Literature DB >> 10027961

Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria.

I Stojiljkovic1, V Kumar, N Srinivasan.   

Abstract

A new group of potent antibacterial compounds, non-iron metalloporphyrins (MPs), is described. MPs possess a strong antibacterial activity against Gram-positive bacteria, Gram-negative bacteria and mycobacteria. Anaerobically grown bacteria and microorganisms that do not respire and/or express haem uptake systems were resistant to MPs. Antibacterial activity of MPs was not affected by known antibiotic resistance mechanisms operating in bacteria. The most potent MP against Y. enterocolitica, methicillin-resistant S. aureus and M. smegmatis was gallium protoporphyrin IX (Ga-PPIX). When tested alone, Ga ions and metal-free porphyrins had approximately 100-fold higher minimum inhibitory concentration (MIC) values for these organisms. Ga-PPIX was not degraded by MP-sensitive bacteria, indicating that the whole molecule is responsible for antibacterial activity. MPs are antibacterial 'Trojan horses', as they exploit haem transport systems of Gram-negative bacteria as portals of entry into the cell. Bacterial mutants in superoxide dismutases, catalases and stationary-phase sigma factors were hypersensitive to Ga-PPIX. The extreme sensitivity of sod mutants to MPs and the requirement for active respiration for MP activity suggests that these compounds stimulate the production of reactive oxygen radicals in bacteria. Ga-PPIX was not toxic to primary human fibroblasts, several established cell lines and experimental animals at concentrations > 100-fold higher than the MIC for sensitive bacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027961     DOI: 10.1046/j.1365-2958.1999.01175.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  80 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 2.  Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens.

Authors:  Laura L Anzaldi; Eric P Skaar
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

3.  Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media.

Authors:  Olga Senkovich; Shantelle Ceaser; David J McGee; Traci L Testerman
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

4.  Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.

Authors:  Maher Y Abdalla; Barbara L Switzer; Christopher H Goss; Moira L Aitken; Pradeep K Singh; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

Review 5.  Targeting iron assimilation to develop new antibacterials.

Authors:  Timothy L Foley; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2012-07-19       Impact factor: 6.098

Review 6.  Antimicrobial activity of metals: mechanisms, molecular targets and applications.

Authors:  Joseph A Lemire; Joe J Harrison; Raymond J Turner
Journal:  Nat Rev Microbiol       Date:  2013-05-13       Impact factor: 60.633

7.  Use of heme compounds as iron sources by pathogenic neisseriae requires the product of the hemO gene.

Authors:  W Zhu; D J Hunt; A R Richardson; I Stojiljkovic
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

8.  The Mannoprotein Cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans.

Authors:  Brigitte Cadieux; Tianshun Lian; Guanggan Hu; Joyce Wang; Carmelo Biondo; Giuseppe Teti; Victor Liu; Michael E P Murphy; A Louise Creagh; James W Kronstad
Journal:  J Infect Dis       Date:  2013-01-15       Impact factor: 5.226

9.  PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA.

Authors:  Michael V Tullius; Susana Nava; Marcus A Horwitz
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

10.  FvtA is the receptor for the siderophore vanchrobactin in Vibrio anguillarum: utility as a route of entry for vanchrobactin analogues.

Authors:  Miguel Balado; Carlos R Osorio; Manuel L Lemos
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.